Despite major progress in interventional and medical treatments, myocardial infarction (MI)
and subsequent development of heart failure (HF) are still associated with high mortality …

Astragalus membranaceus Bunge has been used to treat numerous diseases for thousands
of years. As the main active substance of Astragalus membranaceus Bunge, astragaloside …

Ischemic heart disease (IHD) remains the leading cause of death and disability worldwide.
For patients presenting with an acute myocardial infarction, the most effective treatment for …

Heart diseases due to myocardial ischemia, such as myocardial infarction or ischemic heart
failure, are major causes of death in developed countries, and their number is unfortunately …

Background—In animal models, brief periods of ischemia performed just at the time of
reperfusion can reduce infarct size, a phenomenon called postconditioning. In this …

Therapeutic strategies to protect the ischemic myocardium have been studied extensively.
Reperfusion is the definitive treatment for acute coronary syndromes, especially acute …

Ischaemic postconditioning (brief periods of ischaemia alternating with brief periods of
reflow applied at the onset of reperfusion following sustained ischaemia) effectively reduces …

Context: Recently, vitamin D (VitD) has been recognized as increasingly importance in many
cellular functions of several tissues and organs other than bone. In particular, VitD showed …

Objectives A series of brief coronary artery reperfusions and reocclusions applied during the
early minutes of coronary artery reflow (“postconditioning”) attenuates reperfusion injury …

Background and Purpose—Ischemic postconditioning (Postcond) is defined as a series of
intermittent interruptions of blood flow in the early phase of reperfusion that mechanically …